Carboxymethyl chitosan oligosaccharide prevents the progression of chronic kidney disease as a Nrf2-dependent apoptosis inhibitor

Chronic Kidney Disease (CKD) has become a global public health problem, for which satisfactory treatments remain an urgent need. Carboxymethyl chitosan oligosaccharide (CMCOS) is a small molecule derivative of the natural product chitin, which is easy to absorb with variety of biological activities....

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaozheng Yuan, Huan He, Youtao Xu, Xinru Chen, Jiawen Wu, Xianpeng Zhong, Xiyu Li, Jing Qiao
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Carbohydrate Polymer Technologies and Applications
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666893925000672
Tags: Add Tag
No Tags, Be the first to tag this record!